Skip to main navigation Skip to search Skip to main content

Impact of the COBAS AmpliPrep/COBAS AMPLICOR HIV-1 MONITOR Test, version 1.5, on clinical laboratory operations

  • Jeffrey J. Germer
  • , Jordan L. Bendel
  • , Craig A. Dolenc
  • , Sarah R. Nelson
  • , Amanda L. Masters
  • , Tara M. Gerads
  • , Jayawant N. Mandrekar
  • , P. Shawn Mitchell
  • , Joseph D.C. Yao

Research output: Contribution to journalArticlepeer-review

Abstract

The COBAS AmpliPrep/COBAS AMPLICOR HIV-1 MONITOR Test, version 1.5 (CAP/CA), and the COBAS AMPLICOR HIV-1 MONITOR Test, version 1.5, were compared. CAP/CA reduced and consolidated labor while modestly increasing assay throughput without increased failure rates or direct costs, regardless of batch size and assay format.

Original languageEnglish (US)
Pages (from-to)3101-3104
Number of pages4
JournalJournal of clinical microbiology
Volume45
Issue number9
DOIs
StatePublished - Sep 2007

ASJC Scopus subject areas

  • Microbiology (medical)

Fingerprint

Dive into the research topics of 'Impact of the COBAS AmpliPrep/COBAS AMPLICOR HIV-1 MONITOR Test, version 1.5, on clinical laboratory operations'. Together they form a unique fingerprint.

Cite this